← Leaderboards
Antonio Mutti
University Of Parma
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$1,479,649 · 3
By mechanism
R01$1,479,649 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pathologic Process”
- Paul S. Aisen · Cognition Therapeutics, Inc.$141,221,127
- Reisa A. Sperling · Banner Health$136,913,444
- Constance Ann Benson · University Of California, San Diego$114,806,215
- David A Bennett · Rush University Medical Center$85,949,086
- Stephen A Spector · University Of California, San Diego$77,513,450
- Randall J Bateman · Washington University$70,562,221
Research focus
Pathologic ProcessDisease /Disorder Proneness /RiskMass SpectrometryChronic Obstructive Pulmonary DiseaseBiomarkerBreath CompositionCadmiumChromiumClinical ResearchHuman SubjectItalyLeadLiquid Chromatography Mass SpectrometryMetalloproteinsMetalsNickelOxidative StressPatient Oriented ResearchPeroxidationSmokingTobacco AbuseToxicologyTrace ElementsAldehydes
Grant awards (10)
Metals in exhaled breath condensate as COPD biomarkers$369,028
R01 · FY2005 · HL
Novel Biomarkers of COPD - Parma Site$0
R01 · FY2005 · HL
Novel Biomarkers of COPD - Chicago Site$0
R01 · FY2005 · HL
Metals in exhaled breath condensate as COPD biomarkers$369,289
R01 · FY2004 · HL
Novel Biomarkers of COPD - Chicago Site$0
R01 · FY2004 · HL
Novel Biomarkers of COPD - Parma Site$0
R01 · FY2004 · HL
Metals in exhaled breath condensate as COPD biomarkers$369,543
R01 · FY2003 · HL
Novel Biomarkers of COPD - Parma Site$0
R01 · FY2003 · HL
Novel Biomarkers of COPD - Chicago Site$0
R01 · FY2003 · HL
Metals in exhaled breath condensate as COPD biomarkers$371,789
R01 · FY2002 · HL